Journal
STEM CELL RESEARCH
Volume 55, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2021.102445
Keywords
GATA2 deficiency; Induced Pluripotent stem cells; Gene Editing
Funding
- Fondazione Pisana per la Scienza ONLUS, Pisa, Italy
- Department of Health of the Government of Catalonia under the frame of ERA PerMed [SLT011/18/00006]
- Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) [SAF2016-80205-R]
- CERCA Programme/Generalitat de Catalunya
Ask authors/readers for more resources
The study successfully generated high-quality human induced pluripotent stem cell lines carrying two common GATA2 gene mutations using CRISPR/Cas9, providing an in vitro model for studying the molecular and cellular mechanisms underlying GATA2 deficiency.
Germline heterozygous GATA2 mutations underlie a complex disorder characterized by bone marrow failure, immunodeficiency and high risk to develop myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Our understanding about GATA2 deficiency is limited due to the lack of relevant disease models. Here we generated high quality human induced pluripotent stem cell (iPSC) lines carrying two of the most recurrent germline GATA2 mutations (R389W and R396Q) associated with MDS, using CRISPR/Cas9. These hiPSCs represent an in vitro model to study the molecular and cellular mechanisms underlying GATA2 deficiency, when differentiated into blood progenitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available